BIIB FY 2019 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2019 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$14.4B+6.9% YoY

Gross Profit

$12.4B86.4% margin

Operating Income

$7.0B49.0% margin

Net Income

$5.9B41.0% margin

EPS (Diluted)

$31.42

Cash Flow

Operating Cash Flow

$7.1B

Free Cash Flow

$6.6B

Stock-Based Comp.

$182M

Balance Sheet

Total Assets

$27.2B

Total Liabilities

$13.9B

Stockholders' Equity

$13.3B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14.4B	$13.5B	+6.9%
Gross Profit	$12.4B	$11.6B	+6.8%
Operating Income	$7.0B	$5.9B	+19.6%
Net Income	$5.9B	$4.4B	+32.9%